- Home
- ACXP vs LITB Comparison
ACXP vs LITB Comparison
Compare ACXP & LITB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACXP
- LITB
- Stock Information
- Founded
- ACXP 2017
- LITB 2007
- Country
- ACXP United States
- LITB Singapore
- Employees
- ACXP N/A
- LITB N/A
- Industry
- ACXP Biotechnology: Pharmaceutical Preparations
- LITB Catalog/Specialty Distribution
- Sector
- ACXP Health Care
- LITB Consumer Discretionary
- Exchange
- ACXP Nasdaq
- LITB Nasdaq
- Market Cap
- ACXP 31.4M
- LITB N/A
- IPO Year
- ACXP 2021
- LITB N/A
- Fundamental
- Price
- ACXP $0.46
- LITB $0.99
- Analyst Decision
- ACXP Strong Buy
- LITB
- Analyst Count
- ACXP 1
- LITB 0
- Target Price
- ACXP $12.00
- LITB N/A
- AVG Volume (30 Days)
- ACXP 472.4K
- LITB 20.4K
- Earning Date
- ACXP 03-18-2025
- LITB 03-24-2025
- Dividend Yield
- ACXP N/A
- LITB N/A
- EPS Growth
- ACXP N/A
- LITB N/A
- EPS
- ACXP N/A
- LITB N/A
- Revenue
- ACXP N/A
- LITB $333,093,000.00
- Revenue This Year
- ACXP N/A
- LITB N/A
- Revenue Next Year
- ACXP N/A
- LITB N/A
- P/E Ratio
- ACXP N/A
- LITB N/A
- Revenue Growth
- ACXP N/A
- LITB N/A
- 52 Week Low
- ACXP $0.43
- LITB $0.91
- 52 Week High
- ACXP $3.33
- LITB $6.00
- Technical
- Relative Strength Index (RSI)
- ACXP 30.04
- LITB 39.53
- Support Level
- ACXP $0.60
- LITB $0.92
- Resistance Level
- ACXP $0.67
- LITB $1.05
- Average True Range (ATR)
- ACXP 0.07
- LITB 0.06
- MACD
- ACXP -0.03
- LITB 0.01
- Stochastic Oscillator
- ACXP 6.99
- LITB 26.92
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.